Essential role of glycogen synthase kinase 3 in regulating growth, drug response, and infectivity in Leishmania infantum
Antimicrobial Agents and Chemotherapy · 05.08.2026 · 70 (8)
DOI: 10.1128/aac.00247-26 ↗Kurz gefasst
Fachartikel in der Zeitschrift Antimicrobial Agents and Chemotherapy, erschienen am 05.08.2026. Verfasst von Mariza Gabriela Faleiro de Moura Lodi Cruz und 8 weiteren Autor:innen. Beteiligte Einrichtung: Fundação Oswaldo Cruz-Fiocruz, Instituto René Rachou, Belo Horizonte, Minas Gerais, Brazil. Hauptthemen laut MEDLINE: Leishmania infantum, Glycogen Synthase Kinase 3, Antiprotozoal Agents. Die Arbeit nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Coordenação de Aperfeiçoamento de Pessoal de Nível Superior, Conselho Nacional de Desenvolvimento Científico e Tecnológico, Fundação de Amparo à Pesquisa do Estado de Minas Gerais.
Abstract (Originalsprache)
Leishmania infantum depends on tightly regulated signaling pathways to sustain growth, stress adaptation, and infectivity. Glycogen synthase kinase 3 (GSK-3) is a conserved serine/threonine kinase involved in multiple cellular processes; however, its functional role in Leishmania remains poorly defined. Here, we investigated the role of the short isoform of GSK-3 (GSK-3s) in L. infantum using a CRISPR/Cas9-based genetic approach. Attempts to generate chromosomal GSK-3s null mutants were unsuccessful, suggesting that GSK-3s is essential for parasite viability. Chromosomal gene deletion was achieved only after episomal complementation with L. braziliensis GSK-3s, generating a GSK3s-deficient knockdown L. infantum line ( LiΔchrGSK3::LbGSK3 ). Quantitative PCR revealed a 3.8-fold and 9.6-fold reduction in GSK-3s transcript levels in this L. infantum line compared with Li::Cas9 and GSK3-overexpressing ( Li::LbGSK3 ) parasites, respectively. Reduced GSK-3s expression in this parasite line resulted in severe growth impairment, morphological alterations, and cell-cycle dysregulation. GSK-3s knockdown promastigotes exhibited a 5.3-fold increase in resistance to trivalent antimony and a 1.77-fold increase in resistance to miltefosine, as well as a striking 111-fold increase in resistance to the GSK-3 inhibitor 6-bromo-5-methylindirubin-3′-oxime (6-BIO), supporting the specificity of this compound toward parasite GSK-3s. In addition, GSK-3s-deficient parasites displayed a 7.5-fold increase in tolerance to hydrogen peroxide-induced oxidative stress, accompanied by differential modulation of antioxidant defense gene transcripts. In infection models, GSK-3s knockdown parasites displayed reduced early infectivity in THP-1-derived macrophages and significantly lower splenic parasite burdens, with reductions of 1.5-fold in BALB/c mice and 2.5-fold in IFN- γ ⁻/⁻ C57BL/6 mice. Collectively, these findings suggest that GSK-3s may play an important role in regulating L. infantum growth, stress adaptation, drug response, and infectivity, indicating its potential as a target for anti-leishmanial drug development.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Fundação Oswaldo Cruz-Fiocruz, Instituto René Rachou, Belo Horizonte, Minas Gerais, Brazil.
- Fundação Oswaldo Cruz-Fiocruz, Instituto Carlos Chagas, Curitiba, Paraná, Brazil.
ORCID-Profile: Mariza Gabriela Faleiro de Moura Lodi Cruz, Giovanna Cecília de Paula E Sá, Juliana Martins Ribeiro, Giovanna Ferreira da Fonseca, Davi Alvarenga Lima, Karine Ferreira Lopes, Ana Maria Murta Santi, Silvane Maria Fonseca Murta
Förderung
- Coordenação de Aperfeiçoamento de Pessoal de Nível Superior
- Conselho Nacional de Desenvolvimento Científico e Tecnológico
- Fundação de Amparo à Pesquisa do Estado de Minas Gerais
- Fundação Oswaldo Cruz
Zitieren
APA
Cruz, M. G. F. M. L., Silva, F. V. M., Sá, G. C. P., Ribeiro, J. M., Fonseca, G. F., Lima, D. A., Lopes, K. F., Santi, A. M. M., & Murta, S. M. F. (2026). Essential role of glycogen synthase kinase 3 in regulating growth, drug response, and infectivity in Leishmania infantum. Antimicrobial Agents and Chemotherapy, 70(8). https://doi.org/10.1128/aac.00247-26
Vancouver
Cruz MGFML, Silva FVM, Sá GCP, Ribeiro JM, Fonseca GF, Lima DA, et al. Essential role of glycogen synthase kinase 3 in regulating growth, drug response, and infectivity in Leishmania infantum. Antimicrobial Agents and Chemotherapy. 2026;70(8). doi:10.1128/aac.00247-26
BibTeX
@article{Cruz2026,
author = {Cruz, Mariza Gabriela Faleiro de Moura Lodi and Silva, Fernanda Viana Moreira and Sá, Giovanna Cecília de Paula E and Ribeiro, Juliana Martins and Fonseca, Giovanna Ferreira da and Lima, Davi Alvarenga and Lopes, Karine Ferreira and Santi, Ana Maria Murta and Murta, Silvane Maria Fonseca},
title = {Essential role of glycogen synthase kinase 3 in regulating growth, drug response, and infectivity in Leishmania infantum},
journal = {Antimicrobial Agents and Chemotherapy},
year = {2026},
volume = {70},
number = {8},
doi = {10.1128/aac.00247-26}
}
EUVIMED